Your session is about to expire
← Back to Search
CBD Oil for Postoperative Knee Pain (CBDS Trial)
Phase < 1
Waitlist Available
Research Sponsored by Foundation for Orthopaedic Research and Education
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 or older
Requiring knee arthroscopy for soft tissue injury, acute or chronic knee injury
Must not have
History of knee dislocation, fracture, previous surgery, coexisting extremity pathology
Younger than 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days preoperatively leading up to surgery, then 30 days postoperatively. outcomes will be collected from surgery to 6 weeks postoperatively.
Awards & highlights
No Placebo-Only Group
Summary
This trial compares CBD oil to opioids to see if it can reduce post-op pain after a knee arthroscopy.
Who is the study for?
This trial is for adults over 18 who need a knee arthroscopy due to soft tissue injury or other acute or chronic knee issues. Participants must be able to fill out surveys and come back for follow-ups. It's not for those under 18, with past major knee injuries, surgeries, other limb problems, or if pregnant.
What is being tested?
The study is testing the effectiveness of CBD oil in managing pain after knee surgery compared to traditional opioid medications. Patients are randomly assigned to receive either CBD oil or opioids and their pain levels are monitored.
What are the potential side effects?
CBD oil may cause side effects such as tiredness, diarrhea, changes in appetite/weight. However, it's generally considered well-tolerated; specific side effects related to this trial will be closely monitored.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I need a knee surgery for a tissue injury.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a knee injury, surgery, or other leg issues before.
Select...
I am under 18 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days preoperatively leading up to surgery, then 30 days postoperatively. outcomes will be collected from surgery to 6 weeks postoperatively.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days preoperatively leading up to surgery, then 30 days postoperatively. outcomes will be collected from surgery to 6 weeks postoperatively.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-operative pain control
Secondary study objectives
Sleep Quality
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Cannabidiol Oil 200 mg/dayExperimental Treatment1 Intervention
CBD 200mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively.
Group II: Cannabidiol Oil 100 mg/dayExperimental Treatment1 Intervention
CDB 100mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively
Group III: Standard of CareActive Control1 Intervention
Opioid standard of care: Percocet (oxycodone 5mg-acetaminophen 325 mg) every 4 hours PRN postoperatively for 7 days
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabidiol Oil
2020
Completed Phase 4
~10
Find a Location
Who is running the clinical trial?
Foundation for Orthopaedic Research and EducationLead Sponsor
14 Previous Clinical Trials
901 Total Patients Enrolled
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: Cannabidiol Oil 100 mg/day
- Group 3: Cannabidiol Oil 200 mg/day
Share this study with friends
Copy Link
Messenger